Taletrectinib (AB-106; DS-6051b) in metastatic non-small cell lung cancer (NSCLC) patients with ROS1 fusion: Preliminary results of TRUST.
JOURNAL OF CLINICAL ONCOLOGY(2021)
关键词
lung cancer,ros1 fusion,taletrectinib,non-small
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要